PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. razejahromi@yahoo.com.\', \'Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.\', \'Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Unit of Translational Critical Care Medicine, Institute of Life Sciences, Scuola Superiore Sant\'Anna, Pisa, Italy. vincenzo.lionetti@santannapisa.it.\', \'UOS Anesthesiology and Intensive Care Medicine, Fondazione Toscana G. Monasterio, Pisa, Italy. vincenzo.lionetti@santannapisa.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10741-020-10016-2
?:hasPublicationType
?:journal
  • Heart failure reviews
is ?:pmid of
?:pmid
?:pmid
  • 32844337
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.887
?:rankingScore_hIndex
  • 68
is ?:relation_isRelatedTo_publication of
?:title
  • Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all